Dr. Karen Reckamp, MD

• Hematology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of Chicago Hospital / Roosevelt University

  Medical School, 1998

• English

• Korean

• Evaluation of Somatic Mutations in Solid Metastatic Pan-Cancer Patients, 2021-06-03

• A 75-Year-Old Man With Progressive Bronchioalveolar Carcinoma, 2019-06-28

• Immune Checkpoint and Anti-Angiogenic Antibodies for the Treatment of Non-Small Cell Lung Cancer in the European Union and United States, 2021-06-21

• Long-Term Efficacy and Safety of Brigatinib in Crizotinib-RefractoryALK+ NSCLC: Final Results of the Phase 1/2 and Randomized Phase 2 (ALTA) Trials, 2022-07-31

• Population pharmacokinetic and exposure-response analyses from ALTA-1L: Model-based analyses supporting the brigatinib dose inALK-positive NSCLC GUPTA et al., 2022-02-08

• The Association between Polluted Neighborhoods andTP53-Mutated Non-Small Cell Lung Cancer, 2021-06-04

• Editorial: Impact of immunotherapy in lung cancer, 2022-11-11

• Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878), 2021-05-15

• Co-stimulatory and co-inhibitory immune markers in solid tumors withMETalterations, 2020-11-25

• Longitudinal SARS-CoV-2 mRNA vaccine-induced humoral immune responses in cancer patients, 2021-11-10

• A Lung Cancer Screening Education Program Impacts both Referral Rates and Provider and Medical Assistant Knowledge at Two Federally Qualified Health Centers, 2021-12-12

• Molecular and Clinical Features of Hospital Admissions in Patients with Thoracic Malignancies on Immune Checkpoint Inhibitors, 2021-05-28